Benzinga | Apr 27, 2021 05:02PM EDT

Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

Generation Bio Co. (NASDAQ:GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced three digital presentations at the American Society of Gene & Cell Therapy (ASGCT) 2021 Virtual Annual Meeting taking place May 11-14. The presentations will cover data supporting use of the company's platform for antibody gene therapy, a summary of previously released preclinical data from the hemophilia A program and insight into ceDNA construct engineering for factor VIII.